N
DNMR

Nuveen’s Danimer Scientific, Inc. DNMR Stock Holding History

Nuveen’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,548
Closed -$155K – 3361
2024
Q3 		$155K Hold
8,548
– – ﹤0.01% 3263
2024
Q2 		$206K Sell
8,548
-2,189
-20% -$68.1K ﹤0.01% 3208
2024
Q1 		$468K Buy
10,737
+438
+4% +$18.1K ﹤0.01% 2999
2023
Q4 		$420K Buy
10,299
+768
+8% +$41.8K ﹤0.01% 3062
2023
Q3 		$789K Sell
9,531
-111
-1% -$10.1K ﹤0.01% 2664
2023
Q2 		$918K Buy
9,642
+3,485
+57% +$447K ﹤0.01% 2699
2023
Q1 		$850K Sell
6,157
-651
-10% -$59.5K ﹤0.01% 2665
2022
Q4 		$487K Sell
6,808
-1,167
-15% -$110K ﹤0.01% 2893
2022
Q3 		$941K Buy
7,975
+217
+3% +$38.7K ﹤0.01% 2774
2022
Q2 		$1.42M Sell
7,758
-2,260
-23% -$411K ﹤0.01% 2617
2022
Q1 		$2.29M Buy
10,018
+4,063
+68% +$820K ﹤0.01% 2435
2021
Q4 		$2.54M Buy
5,955
+532
+10% +$293K ﹤0.01% 2455
2021
Q3 		$3.61M Sell
5,423
-534
-9% -$393K ﹤0.01% 2380
2021
Q2 		$5.97M Buy
+5,957
New +$5.94M ﹤0.01% 2155

Other funds holding DNMR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Nuveen's DNMR Position: Q4 2024 in Review

Nuveen sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 8,548 shares — an estimated $155K sold.

Nuveen first reported a position in DNMR in Q2 2021 and held it in 14 quarters. The position peaked at $5.97M in Q2 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Nuveen reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Nuveen sold 8,548 Danimer Scientific, Inc. shares in Q4 2024, an estimated $155K.
  • Nuveen first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 14 quarters.
  • Nuveen's Danimer Scientific, Inc. position peaked at $5.97M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Nuveen's 13F filing for Q4 2024, filed 14 Feb 2025.